| Category : |
Pharmaceuticals and Biochemicals |
 |
| CAS NO : |
864070-44-0 |
| EC NO : |
|
| MF : |
C23H27ClO7 |
| MW : |
450.91618 |
| Specification : |
99% up |
| Packing : |
1kg/bag, 5kg/bag, or as per customers’ requirements. |
| Product description : |
It is an inhibitor of type 2 sodium glucose cotransporter 2 (sglt-2). Sglt-2 inhibitor is a new hypoglycemic drug. It mainly reduces the reabsorption of glucose by kidney and increases the excretion of glucose in urine by inhibiting sglt-2 expressed in urine, so as to reduce the plasma glucose level. Its hypoglycemic effect does not depend on β Cell function
Empagliflozin, sold under the trade name Jardiance among others, is a medication used together with diet and exercise
to treat type 2 diabetes. It is less preferred than metformin and sulfonylureas. It may be used together with other
medications such as metformin It is not recommended for type 1 diabetes. It is taken by mouth. |
| Uses : |
It is an inhibitor of type 2 sodium glucose cotransporter 2 (sglt-2). Sglt-2 inhibitor is a new hypoglycemic drug. |
| Synonyms : |
d-glucitol, 1,5-anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1s)-; |
| Molecular Structure : |
 |